Is Anheuser-Busch InBev Stock a Buy?
The COVID-19 pandemic has brewed strange circumstances for Anheuser-Busch InBev (NYSE: BUD). The Belgium-based beer producer has seen its stock drop as bars close their doors and consumers take their alcohol consumption into the home.
However, the fear of coronavirus appears to have taken InBev stock into oversold territory. Though this may make shares look attractive, investors may want to avoid this name long-term as society moves past COVID-19 and the stock's previous issues return to the forefront.
InBev's troubles did not begin with COVID-19. Its stock peaked in 2016 at $136.08 per share. It has seen a slow decline since that time, but its drop in value accelerated amid pandemic-induced selling.
Source Fool.com


